Application 211639
- Type
- ANDA
- Sponsor
- AUROLIFE PHARMA LLC
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | AMPHETAMINE SULFATE | AMPHETAMINE SULFATE | TABLET;ORAL | 5MG | No | No |
| 002 | AMPHETAMINE SULFATE | AMPHETAMINE SULFATE | TABLET;ORAL | 10MG | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 13107-259 | Amphetamine Sulfate | Amphetamine Sulfate | Aurolife Pharma, LLC | ANDA | Current |
| 13107-259 | Amphetamine Sulfate | Amphetamine Sulfate | Aurolife Pharma, LLC | ANDA | Current |
| 13107-259 | Amphetamine Sulfate | Amphetamine Sulfate | Aurolife Pharma, LLC | ANDA | Current |
| 13107-259 | Amphetamine Sulfate | Amphetamine Sulfate | Aurolife Pharma, LLC | ANDA | Current |
| 13107-260 | Amphetamine Sulfate | Amphetamine Sulfate | Aurolife Pharma, LLC | ANDA | Current |
| 13107-260 | Amphetamine Sulfate | Amphetamine Sulfate | Aurolife Pharma, LLC | ANDA | Current |
| 13107-260 | Amphetamine Sulfate | Amphetamine Sulfate | Aurolife Pharma, LLC | ANDA | Current |
| 13107-260 | Amphetamine Sulfate | Amphetamine Sulfate | Aurolife Pharma, LLC | ANDA | Current |